Society Members Recognized by ADA

Three Endocrine Society members have been recognized by the American Diabetes Association® (ADA) as recipients of its 2020 National Scientific and Health Care Achievement Awards.

The awards recognize academics, healthcare providers, and educators who have contributed to tangible advances in the field of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of diabetes and all its burdens.

The following award recipients will be recognized at an awards ceremony scheduled to take place at the ADA’s 80th Scientific Sessions, June 12-16, 2020, in Chicago, Ill.:

  • Jiandie Lin, PhD, is the recipient of the 2020 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality. Lin has contributed to our understanding of inter-organ crosstalk of emerging endocrine hormones and has performed pioneering work in chromatin control of metabolic gene programs.
  • Bernard Zinman, CM, MD, FRCPC, FACP, is the recipient of the 2020 research accomplishments, including serving as lead investigator in several large international trials such as the Diabetes Control and Complications trial (DCCT), have had significant impact on the management of both type 1 and type 2 diabetes.
  • Elizabeth R. Seaquist, MD, is the recipient of the 2020 Albert Renold Award, which is presented to an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the development of communities of scientists to enhance diabetes research. Seaquist has trained and mentored a generation of junior faculty who are now emerging leaders in the field of diabetes research.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in